Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Binovi Technologies Corp. EYCCF


Primary Symbol: BNVIF

Binovi Technologies Corp is a human performance technology company that has developed Binovi, a hardware and software-centered platform. Binovi combines hardware, software, specialized knowledge, and big data insights in order to deliver customized one-on-one training and treatment. Binovi is designed for vision optimization and the enhancement of cognitive skills related to human performance. The company is working together under a common banner to help neuro-optometry, vision rehabilitation, a


GREY:BNVIF - Post by User

Post by RichyRich$on Apr 21, 2022 5:34am
155 Views
Post# 34619179

New CEO Since January 2022 (StockWatch News)

New CEO Since January 2022 (StockWatch News)2022-01-05 18:59 ET - News Release Mr. Terry Booth reports BINOVI APPOINTS DHALIWAL AS ITS NEW CEO AND TO THE BOARD OF DIRECTORS Binovi Technologies Corp. has appointed Jatinder Dhaliwal to the company's board of directors and has been appointed chief executive officer. Marc Lakmaaker has resigned, effective immediately, as interim chief executive officer and director. Mr. Dhaliwal is a registered pharmacist, CEO and director of multiple publicly traded companies. He has extensive knowledge in agricultural, medical and pharmaceutical operations. Mr. Dhaliwal holds a bachelor of pharmacy from the University of British Columbia and a bachelor of science in biology from the University of Victoria. Mr. Dhaliwal has overseen the acquisition and development of numerous projects, technology platforms and applications. He has overseen operations of numerous retail and commercial operations and implemented various health protocols and technology advances into health and wellness chains. Terry Booth, chairman of the board, commented: "With Mr. Dhaliwal's appointment, Binovi will enhance its access to capital markets and health care industry networks, which will be valuable assets towards the execution on Binovi's strategy and conversion of business prospects. I would like to thank Marc for taking on the role as interim CEO, in which capacity he successfully led crucial clean-up efforts and spearheaded important initiatives that we believe will create significant value for the company going forward."
<< Previous
Bullboard Posts
Next >>